Lisa Heberling
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.
Journal: Leukemia & lymphoma
Published: August 02, 2026
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial.
Journal: Annals of hematology
Published: November 14, 2025
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: February 08, 2025
Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia.
Journal: Leukemia
Published: September 26, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026